XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
REVENUE (Tables)
6 Months Ended
Apr. 30, 2022
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
Three Months Ended April 30,
20222021
Life Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
TotalLife Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
Total
(in millions)
Revenue by Region
Americas$321 $137 $201 $659 $296 $122 $163 $581 
Europe216 97 110 423 214 95 106 415 
Asia Pacific359 119 47 525 371 112 46 529 
Total$896 $353 $358 $1,607 $881 $329 $315 $1,525 
Six Months Ended April 30,
20222021
Life Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
TotalLife Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
Total
(in millions)
Revenue by Region
Americas$638 $269 $389 $1,296 $575 $246 $315 $1,136 
Europe468 195 211 874 459 187 206 852 
Asia Pacific766 248 97 1,111 770 227 88 1,085 
Total$1,872 $712 $697 $3,281 $1,804 $660 $609 $3,073 
The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
Three Months EndedSix Months Ended
April 30,April 30,
2022202120222021
(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical$589 $531 $1,191 $1,052 
Chemical and Energy335 314 708 642 
Diagnostics and Clinical241 233 484 449 
Food137 144 295 306 
Academia and Government146 143 287 285 
Environmental and Forensics159 160 316 339 
Total$1,607 $1,525 $3,281 $3,073 
Revenue by Type
Instrumentation$646 $632 $1,337 $1,313 
Non-instrumentation and other961 893 1,944 1,760 
Total$1,607 $1,525 $3,281 $3,073 
Contract Liabilities and Changes in Balances
The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the six months ended April 30, 2022:
Contract
Liabilities
(in millions)
Ending balance as of October 31, 2021$519 
Net revenue deferred in the period332 
Revenue recognized that was included in the contract liability balance at the beginning of the period(283)
Change in deferrals from customer cash advances, net of revenue recognized48 
Currency translation and other adjustments(19)
Ending balance as of April 30, 2022$597